Search

everythinglearnresearchcommunity

for

Search:↓

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib taken by mouth helps treat hair loss in children.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Tofacitinib treatment for hair loss may worsen acne.

Pexidartinib often causes liver issues and fatigue, especially in women.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib, a hair regrowth treatment, may worsen acne.